### **Overview** Sastasundar Ventures Limited (SVL), headquartered in Kolkata, India (CIN: L74110WB1992PLC051745), is a digitally integrated healthcare platform company operating at the intersection of B2B and B2C e-pharmacy, wellness, diagnostics, and AI-driven health tech solutions. The company is led by Founder and Executive Chairman Mr. B. L. Mittal, a veteran with over 25 years of experience in financial services and digital healthcare. SVL operates through a dual-platform model: - **SastaSundar App (B2C)**: Direct-to-consumer platform offering pharmacy, wellness, diagnostics, and soon, teleconsultations. - **RetailerShakti (B2B)**: A digital supply chain platform distributing pharmaceuticals, OTC, wellness, and FMCG products to over 28,000 retail pharmacies and kirana stores nationwide. The group’s healthcare arm is anchored by **Sastasundar Healthbuddy Limited (SHBL)**, a key subsidiary engaged in wholesale trading of medicines and healthcare products, with SVL increasing its ownership stake from 72.14% to **78.89%** in Nov 2025 by buying back Mitsubishi Corporation’s stake. This marks a strategic move toward corporate simplification, including an upcoming merger/demerger scheme to be reviewed by the board by March 31, 2026. --- ### **Core Business Segments & Subsidiaries** | Entity | Role | |-------|------| | **SastaSundar Healthbuddy Limited (SHBL)** | Wholesale trading of medicines, healthcare, and OTC products via a pan-India warehouse network. | | **Retailer Shakti Supply Chain Pvt. Ltd. (RSSCPL)** | Operates the B2B digital platforms **RetailerShakti.com** and app; supplies bulk inventory to retailers. | | **Genu Path Labs Limited** | Step-down subsidiary running the diagnostics business, offering NABL-accredited tests across Eastern India with plans for national scale. | | **SastaSundar Healthtech Pvt. Ltd.** | Owns the SastaSundar brand, IP, domains, and technology stack, including AI tools and apps. | | **Happymate Foods Limited / Myjoy Technologies** | Part of diversified group holdings, though private-label F&B now fully aligned under SastaSundar brand. | --- ### **Strategic Growth Initiatives (Nov 2025 Update)** #### **1. Platform Expansion into High-Margin Categories** - Leveraged existing B2B infrastructure (technology, logistics, warehousing, customer base) to enter high-margin **beauty & personal care** with **zero incremental capex**. - Launched dedicated D2C brand **"Mobat [Mohbbat]"** within the SastaSundar app to avoid **brand confusion with pharmaceuticals**. #### **2. SaaS & Warehouse-as-a-Service Offerings** - Monetizing operational strengths by launching **SaaS and warehouse-as-a-service solutions** for third-party players in: - Personal care - Beauty care - Surgical care - Utilizes **RetailerShakti software**, **logistics network**, and **data-driven supply chain**. - **No inventory investment required** — pure service model targeting brands struggling with Indian distribution. #### **3. AI-Powered Automation & Efficiency Gains** - Achieved **3x warehouse capacity growth** without significant capital outlay via AI-driven process automation. - AI applications now used in: - Script-level recognition - Order picking & sorting - Store identification - Logistics routing - **Operational cost reductions**: - 50% reduction in call center staffing via automated call monitoring. - Reduced coding and back-end operational costs via AI tools. - Automation in Baruipur doubled capacity; expected to **triple within three months**. #### **4. Logistics & Fulfillment Scalability** - Plans to build **two new warehouses in Lucknow and Udaipur**, joining existing hubs in **Kolkata and Noida**. - From these three strategic nodes, aims to cover: **Bihar, Jharkhand, Chhattisgarh, Rajasthan, UP, Haryana, Uttarakhand**. - Noida warehouse undergoing **capacity expansion with automation**. #### **5. Technology & Product Innovation** - Launched flagship private label: **JITO** - Offers **up to 60% savings** on quality-assured generic medicines. - Paired branded drugs with generics to improve affordability and margins. - Developing **"Quick Health"** — an AI-powered **teleconsultation-first** service, differentiating from mere medicine delivery models. - Investing ₹50 crore in current year (vs ₹35 crore prior year), primarily in AI, product development, and team expansion. --- ### **Digital Ecosystem & Brand Building** - **SastaSundar App**: Relaunched post-Flipkart partnership resolution; focuses on savings, quality, and accessibility. - **"Genu Health" App (in development)**: - Integrated D2C platform for **preventive care, diagnostics, e-consultations, hospital coordination, and digital health records**. - AI/ML for predictive analytics and clinical support. - **YouTube Health Education Platform**: “**Sastasundar Health & Happiness Podcast**” - Features **recognized medical professionals**. - Partners with pharma companies for monetization. - Addresses misinformation in local languages. --- ### **Market Positioning & Strategic Shifts** #### **From Flipkart Exit to Independence** - Dissolved strategic partnership with Flipkart Health+; now operates 100%-owned **SastaSundar app**. - Experience from Flipkart collaboration contributed to **internal learning and technological maturity**. - B2C segment, which saw de-growth earlier, is now back on growth trajectory. #### **Focus on Sustainable, Profitable Growth** - Shifted focus from cash-burning expansion to **profitable scaling**. - Platforms now **customer-validated** with established fulfillment centers, teams, and user bases. - Emphasis on **platform business model** with monetization in **product distribution and digital health services**. #### **Pan-India Expansion Strategy** - Leveraging smartphone penetration (>600 million users) for digital healthcare access. - Genu Path Labs focused initially on **Eastern India (Tier II/III cities)** to capture unorganized market share. - Diagnostic services integrated into SastaSundar app; gaining traction with users. --- ### **Competitive Edge** - **Proprietary 'Genu Security Check'** for genuine medicines. - **Data-driven, AI-powered supply chain** with real-time inventory visibility. - Hybrid **online + offline delivery model** via Healthbuddies. - One of the few to offer **end-to-end integrated healthcare**: pharmacy, wellness, diagnostics, education, and soon, consultations.